Biocon Q1 Results: Profit Slumps 95% Even As Revenue Rises

Revenue up 14.8% to Rs 3,941.9 crore.

Biocon reports 95% decrease in year-on-year net profit. (Photo Source: Company website)

Biocon Ltd. reported a 95% fall in net profit for the first quarter of financial year 2026.

The pharma company reported a consolidated bottom line of Rs 31.4 crore, a sharp fall from net profit of Rs 659.70 crore in the year-ago period.

Biocon Q1 Highlights (Consolidated, YoY)

  • Revenue up 14.8% to Rs 3,941.90 crore versus Rs 3,432.90 crore.

  • Net profit down 95% to Rs 31.40 crore versus Rs 659.70 crore.

  • Ebitda up 21% to Rs 748.90 crore versus Rs 620.40 crore.

  • Margin at 19% versus 18.1%

Also Read: Q1 Result Updates: Biocon Profit Falls 95%, Titan Beats Estimates; BSE, HPCL Revenue Rises

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
WRITTEN BY
Khushi Maheshwari
Khushi hails from Aligarh and is a desk writer at NDTV Profit after passing... more
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google